FMS
Fresenius Medical Care Corporation
NYSE: FMS · HEALTHCARE · MEDICAL CARE FACILITIES
$22.16
-1.55% today
Updated 2026-04-29
Market cap
$12.44B
P/E ratio
11.56
P/S ratio
0.63x
EPS (TTM)
$1.97
Dividend yield
3.58%
52W range
$21 – $30
Volume
0.6M
WallStSmart proprietary scores
62
out of 100
Grade: C+
Hold
Investment rating
5.3
Growth
C+6.0
Quality
B5.0
Profitability
C+9.3
Valuation
A+6/9
Piotroski F-Score
Moderate
1.8
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$27.51
+24.14%
12-Month target
$27.98
+26.26%
Intrinsic (DCF)
$101.76
Margin of safety
+76.37%
0 Strong Buy2 Buy3 Hold1 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $564.11M — positive
+ 76.37% below intrinsic value
Risks
- Thin margins at 4.99%
- Revenue declining -0.30% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $19.40B | $19.45B | $19.34B | $19.63B | $19.63B |
| Net income | $673.40M | $499.00M | $537.91M | $978.00M | $327.00M |
| EPS | — | — | — | — | $1.97 |
| Free cash flow | $756.00M | $1.94B | $1.69B | $1.70B | $564.11M |
| Profit margin | 3.47% | 2.57% | 2.78% | 4.98% | 4.99% |
Peer comparison
Smart narrative
Fresenius Medical Care Corporation trades at $22.16. representing a P/E of 11.56x trailing earnings. Our Smart Value Score of 62/100 indicates the stock is good. The company scores 6/9 on the Piotroski F-Score. With an Altman Z-Score of 1.82, it sits in the grey zone. TTM revenue stands at $19.63B. with profit margins at 4.99%. Our DCF model estimates intrinsic value at $101.76.
Frequently asked questions
What is Fresenius Medical Care Corporation's stock price?
Fresenius Medical Care Corporation (FMS) trades at $22.16.
Is Fresenius Medical Care Corporation overvalued?
Smart Value Score 62/100 (Grade C+, Hold). DCF value $101.76.
What is the price target of Fresenius Medical Care Corporation (FMS)?
The analyst target price is $27.51, representing +24.1% upside from the current price of $22.16.
What is the intrinsic value of Fresenius Medical Care Corporation (FMS)?
Based on our DCF model, intrinsic value is $101.76, a +76.4% margin of safety versus $22.16.
What is the future stock price of FMS by 2030?
Our revenue-driven model estimates Fresenius Medical Care Corporation could reach $21.71 by 2030, based on historical CAGR, margin trends, and capped P/E multiples.
What is Fresenius Medical Care Corporation's revenue?
TTM revenue is $19.63B.
Piotroski F-Score?
6/9 — moderate financial health.
Altman Z-Score?
1.82 — grey zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.63x
ROE7.93%
Beta0.85
50D MA$23.04
200D MA$24.31
Shares out0.55B
Float0.19B
Short ratio—
Avg volume0.6M
Performance
1 week-2.55%
1 month-1.77%
3 months-1.60%
YTD-6.97%
1 year—
3 years—
5 years—